Virtual Reality Treatment for Trauma Related to COVID-19 Infection
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-64
SponsorSoonchunhyang University Hospital
About this trial
This clinical trial aims to develop and evaluate the effectiveness of virtual reality (VR)-based exposure therapy for trauma symptoms related to COVID-19 infection. The intervention targets healthcare workers and individuals from the general population who experienced pandemic-related psychological distress. The study assesses psychological and physiological outcomes, including PTSD, anxiety, depression, HRV, and EEG biomarkers.
Eligibility criteria
Qualifiers
Age 18-64, healthy population who survived from COVID-19 (COVID survivors) or Healthcare Workers with PCL-5 ≥10, GAD-7/PHQ-9 ≥10
Disqualifiers
Pregnancy, neurological disorders, severe medical conditions
Trial design
Treatments tested in this trial
- VR Exposure Therapy
- Cognitive Behavioral Therapy (CBT)
- Supportive Psychotherapy
Treatment groups
100 Participants
are divided into 4 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov